BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 136 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,982,067 | -37.5% | 360,758 | 0.0% | 4.17% | -21.9% |
| Q2 2023 | $7,972,751 | +1.6% | 360,758 | 0.0% | 5.34% | +1.3% |
| Q1 2023 | $7,846,486 | +41.4% | 360,758 | +18.3% | 5.27% | +40.6% |
| Q4 2022 | $5,549,362 | -20.0% | 304,910 | 0.0% | 3.75% | -16.6% |
| Q3 2022 | $6,937,000 | +64.7% | 304,910 | 0.0% | 4.49% | +76.2% |
| Q2 2022 | $4,211,000 | -10.1% | 304,910 | +48.0% | 2.55% | +18.2% |
| Q1 2022 | $4,682,000 | -28.3% | 205,968 | +17.5% | 2.16% | -16.9% |
| Q4 2021 | $6,532,000 | -11.9% | 175,275 | 0.0% | 2.60% | -11.8% |
| Q3 2021 | $7,418,000 | -14.4% | 175,275 | -10.0% | 2.94% | -10.7% |
| Q2 2021 | $8,668,000 | +23.6% | 194,750 | 0.0% | 3.30% | +14.1% |
| Q1 2021 | $7,011,000 | -9.8% | 194,750 | 0.0% | 2.89% | -17.3% |
| Q4 2020 | $7,769,000 | +37.8% | 194,750 | 0.0% | 3.49% | +0.9% |
| Q3 2020 | $5,636,000 | +189.0% | 194,750 | +63.3% | 3.46% | +146.6% |
| Q2 2020 | $1,950,000 | – | 119,281 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |